ARKAY ARKAY is a pharmaceutical company that develops RK-01, an orally-active pancreatic beta-cell-centric combination product that provides sustained glycemic control for patients with Type 2 diabetes. | |||
Founding Date | Founding Date 1989 | Founding Date 2017 | Founding Date 2014 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Macierzysz, PL HQ | Locations Basel, CH HQ | Locations Windsor, US HQ |
Employees | Employees 361 | Employees 10 | Employees 1 |
ARKAY is a pharmaceutical company that develops RK-01, an orally-active pancreatic beta-cell-centric combination product that provides sustained glycemic control for patients with Type 2 diabetes.
View company